Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model.
Journal: Journal of medicinal chemistry
Published: May 15, 2024
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs.
Journal: Substance abuse treatment, prevention, and policy
Published: June 29, 2022
Antibody targeting of E3 ubiquitin ligases for receptor degradation.
Journal: Nature
Published: November 03, 2021
CRAF dimerization with ARAF regulates KRAS-driven tumor growth.
Journal: Cell reports
Published: December 08, 2020
IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
Journal: Cancer research
Published: October 04, 2019
Disruption of IRE1α through its kinase domain attenuates multiple myeloma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 03, 2019
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer.
Journal: Cancer research
Published: July 08, 2018
The Addiction Benefits Scorecard: A Framework to Promote Health Insurer Accountability and Support Consumer Engagement.
Journal: Journal of psychoactive drugs
Published: March 18, 2017
Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1.
Journal: Toxicologic pathology
Published: December 23, 2015
Last Updated: 09/26/2026